Guardant Health Showcases New Data Underscoring Power of Blood-Based Cancer Screening at ACG 2025 a leading precision oncology company, today announced that it will present new research data at the American College of Gastroenterology (ACG) 2025 Annual Meeting in Phoenix,…
Hyundai Translead to Become Official Distributor of Hyundai’s XCIENT Fuel Cell Trucks in North America In a strategic move that underscores Hyundai’s accelerating commitment to zero-emission commercial mobility, Hyundai Translead has been appointed as the official distributor of Hyundai Motor…
D-Wave Expands Quantum Computing Education in Italy Through National Seminar Series COMO, Italy – [Date], 2025 – D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave” or the “Company”), a global leader in quantum computing systems, software, and services, and the world’s first…
MindWalk Holdings Appoints R. Scott Areglado as Chief Financial Officer to Advance Financial Strategy and Support Global Growth MINNEAPOLIS, MN – October 23, 2025 – MindWalk Holdings Corp.™ (“MindWalk,” “the Company,” “we,” or “us”) (Nasdaq: HYFT), a bio-native artificial intelligence…
Stevanato Group S.p.A. to Announce Third Quarter 2025 Financial Results on November 6, 2025 Stevanato Group S.p.A. (NYSE: STVN) (“Stevanato Group” or “the Company”), a leading global provider of drug containment, drug delivery, and diagnostic solutions serving the pharmaceutical, biotechnology,…
Thermo Fisher Scientific Reports Strong Third Quarter 2025 Results, Advances Innovation and Strategic Growth WALTHAM, Mass., October 22, 2025 — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced its financial results for the third…
ProImmune Expands Global Headquarters to Drive Next-Generation Immunology and Life Science Innovation ProImmune Ltd, a global leader in life science reagents and immunology services, has officially opened its new global headquarters at Oasis Park in Oxford. The move marks a…
Global Study Highlights Survival Benefit of Mogamulizumab in Advanced Cutaneous T-Cell Lymphoma Birmingham, UK, and Tokyo, Japan – Kyowa Kirin International (KKI), a wholly owned subsidiary of Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin), a Japan-based global specialty pharmaceutical company,…
Satellos Bioscience Doses First Adult Patient in LT-001, a Long-Term Follow-Up Study of SAT-3247 in Duchenne Muscular Dystroph Toronto, Ontario — [Insert Date], 2025 — Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) (“Satellos” or the “Company”), a clinical-stage biotechnology company…
Samsung Bioepis and Phrontline Biopharma Enter Global Collaboration to Advance Next-Generation Antibody-Drug Conjugates for Solid Tumors Samsung Bioepis Co., Ltd., a leading global biopharmaceutical company, and Phrontline Biopharma, a clinical-stage biotechnology firm pioneering a new generation of Antibody-Drug Conjugates (ADCs),…